Sampre Nutritions Limited has announced a crucial board meeting scheduled for September 19, 2025, to deliberate on two significant corporate actions that could potentially benefit its shareholders.

Key Agenda Items

Stock Split Consideration

The board will evaluate the possibility of a sub-division or split of the company's equity shares under Section 61(1)(d) of the Companies Act, 2013. A stock split would increase the number of outstanding shares while proportionately reducing the price per share, potentially making the stock more accessible to a broader range of investors.

Bonus Share Issuance

Directors will consider proposing the issuance of bonus equity shares to existing eligible members of the company. Bonus shares are additional shares given to current shareholders without any cost, effectively increasing their shareholding without diluting the value of their investment.

Meeting Details

The meeting notice, signed by Managing Director Brahma Gurbani on September 15, 2025, was filed with the BSE Limited as per the regulatory requirements. The company adhered to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, in providing this intimation.

Company Background

Sampre Nutritions Limited, with its registered office and manufacturing units located in Medchal, Telangana, operates in the food processing sector. The company has been in operation since its incorporation in 1991.

Implications for Investors

While the outcomes of the board meeting are yet to be determined, both potential actions—stock split and bonus share issuance—are generally viewed favorably by the market. These corporate actions, if approved, could enhance liquidity in the stock and reward existing shareholders.

Investors and market participants will be keenly awaiting the decisions from this upcoming board meeting, as they could significantly impact the company's share structure and valuation in the near term.

Note: Investors are advised to wait for the official announcement post the board meeting for confirmed details on these corporate actions.

Sampre Nutritions has secured a significant manufacturing agreement with Tolaram Wellness Ltd., marking a major milestone for the Telangana-based company. The three-year contract, signed on August 16, 2025, is set to boost Sampre Nutritions' revenue by an estimated INR 10.00 crores annually, totaling INR 30.00 crores over the agreement's duration.

Deal Highlights

Agreement Terms

Under the terms of the agreement, Sampre Nutritions will exclusively manufacture and supply nutraceutical and food products for Tolaram Wellness. The products will be produced according to mutually agreed specifications and quality standards, enabling Tolaram Wellness to market and distribute them effectively.

Key aspects of the deal include:

• Pricing to be mutually agreed upon
• Payment terms: 50% advance, balance on dispatch
• Transportation costs to be borne by Tolaram Wellness

Strategic Implications

This partnership is expected to significantly contribute to Sampre Nutritions' revenue stream and support its operations in the nutraceutical and food product sectors. The agreement aligns with the company's focus on expanding its manufacturing capabilities and client base in the health food industry.

Corporate Governance

Sampre Nutritions has confirmed that this agreement does not constitute a related party transaction. The company disclosed that neither Tolaram Wellness nor any parties involved in the agreement are related to Sampre Nutritions' promoter group or group companies.

Market Impact

The announcement, made on August 28, 2025, underscores Sampre Nutritions' commitment to transparency and compliance with SEBI regulations. This strategic move is likely to be viewed positively by investors, potentially impacting the company's market performance in the coming quarters.

As the nutraceutical market continues to grow globally, this partnership positions Sampre Nutritions to capitalize on the increasing demand for health and wellness products, potentially opening doors for further expansion and collaborations in the future.